Truscreen GroupASX:TRU PB Ratio is 4.33 as of Jul. 12, 2026, which is 48% above its 10-year median of 2.93. The stock has 4 warning signs investors should review. Among 788 Medical Devices & Instruments companies, Truscreen Group ranks worse than 81.22% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-12), Truscreen Group's share price is A$0.013. Truscreen Group's Book Value per Share for the quarter that ended in Mar. 2026 was A$0.00. Hence, Truscreen Group's PB Ratio of today is 4.33.
Good Sign:
Truscreen Group Ltd stock PB Ratio (=5.33) is close to 1-year low of 5.
The historical rank and industry rank for Truscreen Group's PB Ratio or its related term are showing as below:
ASX:TRU'
s PB Ratio Range Over the Past 10 Years
Min: 1.35 Med: 2.93 Max: 14.6
Current: 5.33
During the past 12 years, Truscreen Group's highest PB Ratio was 14.60. The lowest was 1.35. And the median was 2.93.
ASX:TRU's PB Ratio is ranked worse than 81.22% of 788
companies
in the Medical Devices & Instruments industry
Industry Median: 2.065
vs ASX:TRU: 5.33
During the past 12 months, Truscreen Group's average Book Value Per Share Growth Rate was 50.00% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -20.60% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -35.50% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was -31.90% per year.
During the past 12 years, the highest 3-Year average Book Value Per Share Growth Rate of Truscreen Group was -1.30% per year. The lowest was -44.60% per year. And the median was -24.70% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Truscreen Group PB Ratio Related Terms
Truscreen Group PB Ratio Historical Data
* Premium members only.
The historical data trend for Truscreen Group's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Truscreen Group's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Truscreen Group PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Truscreen Group's PB Ratio distribution charts can be found below:
* The bar in red indicates where Truscreen Group's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Truscreen Group's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Truscreen Group (ASX:TRU) has a PB Ratio of 4.33 as of Jul. 12, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Truscreen Group and its competitors. This is 48% above median its historical median of 2.93. Over the past decade, Truscreen Group's PB Ratio has ranged from 1.35 to 14.60. According to the industry distribution chart, Truscreen Group ranks #640 out of 788 companies in the Medical Devices & Instruments industry, placing it in the top 81.2%.
Is Truscreen Group's PB Ratio too high?
Truscreen Group's current PB Ratio of 4.33 is 48% above median its 10-year median of 2.93. Over the past 10 years, this metric has ranged from a low of 1.35 to a high of 14.60. The Medical Devices & Instruments industry median PB Ratio is 2.07. Truscreen Group's value of 4.33 is 109.7% above this industry median. Based on the distribution chart, Truscreen Group ranks #640 out of 788 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does Truscreen Group's PB Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Truscreen Group ranks #640 out of 788 companies for PB Ratio. This places Truscreen Group in the lower half of its industry. The industry median PB Ratio is 2.07. Truscreen Group's value of 4.33 is 109.7% above this benchmark. Historically, Truscreen Group's own PB Ratio has ranged from 1.35 to 14.60 over the past decade. While the company's 10-year median is 2.93 vs. the industry median of 2.07, Truscreen Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.07, based on 788 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Truscreen Group's current PB Ratio of 4.33 is 109.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Truscreen Group and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Truscreen Group's current PB Ratio is 4.33, which is 48% above median its own 10-year median of 2.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Truscreen Group stock overvalued right now?
Based on GuruFocus' analysis, Truscreen Group (ASX:TRU) is currently considered Modestly Overvalued. The stock's GF Value™ is A$0.01, compared to a current price of A$0.01 — trading 30% above its estimated fair value. The current PB Ratio is 4.33, which is 48% above median its 10-year median of 2.93 and 109.7% above the Medical Devices & Instruments industry median of 2.07. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Truscreen Group (ASX:TRU), the current PB Ratio is 4.33 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Truscreen Group Ltd is a medical device company. The company manufactures and distributes the Truscreen Cervical Cancer screening device, which comprises a medical device and process designed to detect the presence in real-time of precancerous and cancerous tissue on the cervix. The product utilizes technology to detect the pre-cancerous change, or cervical intraepithelial neoplasia (CIN), by optical and electrical measurements of cervical tissue. Geographically, the company operates its business in New Zealand, Mexico, China, Russia, Zimbabwe, Vietnam, and other countries. Maximum revenue is generated from China.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:TRU has been successfully added to your 